Top

Reviews in Endocrine and Metabolic Disorders

Published in:

01-12-2017

Editorial

Neuroendocrine neoplasms

Authors: Christian A. Koch, Stephan Petersenn

Published in: Reviews in Endocrine and Metabolic Disorders | Issue 4/2017

Excerpt

It is with great pleasure to introduce Prof. Stephan Petersenn as the guest editor for two special issues on the topic neuroendocrine neoplasms (NEN) in this journal. I have known this top notch expert for the last 15 years after we first had some discussions on how to manage several of such patients with NEN and pursue some research projects. At that time, besides other pursuits, Prof. Petersenn investigated various tissues for the expression of somatostatin receptor subtypes [1, 2]. Prof. Petersenn has brought together a wonderful group of experts in the field NEN and we decided to split the articles into two guest issues of Reviews in Endocrine & Metabolic Disorders. …

Unger N, Serdiuk I, Sheu SY, Walz MK, Schulz S, Schmid KW, et al. Immunohistochemical determination of somatostatin receptor subtypes 1,2A, 3,4, and 5 in various adrenal tumors. Endocr Res. 2004;30(4):931–4. https://doi.org/10.1081/ERC-200044161.CrossRefPubMed

Unger N, Ueberberg B, Schulz S, Saeger W, Mann K, Petersenn S. Differential expression of somatostatin receptor subtype 1-5 proteins in numerous human normal tissues. Exp Clin Endocrinol Diabetes. 2012;120(8):482–9. https://doi.org/10.1055/s-0032-1314859.CrossRefPubMed

Osamura RY, Kovacs K, Lopes MBS, Mete O, Nishioka H. Paraganglioma. Page 50. In: Lloyd RV, Osamura RY, Kloppel G, Rosai J, editors. WHO classification of Tumours of endocrine organs, 4th edition, volume 10. Lyon: WHO Blue Book Series; 2017. ISBN: 978-92-832-4493-6.

Koch CA, Azumi N, Furlong M, Jha RC, Kehoe T, Trowbridge C, et al. Carcinoid syndrome caused by an atypical carcinoid of the uterine cervix. J Clin Endocrinol Metab. 1999;84(11):4209–13. https://doi.org/10.1210/jcem.84.11.6126.CrossRefPubMed

Miehle K, Tannapfel A, Lamesch P, Borte G, Schenker E, Kluge R, et al. Pancreatic neuroendocrine tumor with ectopic ACTH-production upon second recurrence. J Clin Endocrinol Metab. 2004;89(8):3731–6. https://doi.org/10.1210/jc.2003-032164.CrossRefPubMed

East HE, Subauste JS, Gandhi A, Koch CA. About secondary causes of diabetes mellitus. J Miss State Med Assoc. 2012;53(11):380–3.PubMed

Trantakis C, Koch CA, Tannapfel A, Meixensberger J, Drynda K, Führer D. Acromegaly caused by a thoracic neuroendocrine tumor. Exp Clin Endocrinol Diabetes. 2005;S67:113–58.

Florez JC, Shepard JA, Kradin RL. Case records of the Massachusetts General Hospital. Case 17-2013. A 56-year-old woman with poorly controlled diabetes mellitus and fatigue. N Engl J Med. 2013;368(22):2126–36. https://doi.org/10.1056/NEJMcpc1215971.CrossRefPubMed

Hannah-Shmouni F, Stratakis CA, Koch CA. Flushing in (neuro)endocrinology. Rev Endocr Metab Disord. 2016;17(3):373–80. https://doi.org/10.1007/s11154-016-9394-8.CrossRefPubMedPubMedCentral

10.

Lewin KJ, Dowling F, Wright JP, Taylor KB. Gastric morphology and serum gastrin levels in pernicious anemia. Gut. 1976;17(7):551–60. https://doi.org/10.1136/gut.17.7.551.CrossRefPubMedPubMedCentral

11.

Kahaly GJ, Algeciras-Schimnich A, Davis TE, Diana T, Feldkamp J, Karger S, et al. United States and European multicenter prospective study for the analytical performance and clinical validation of a novel sensitive fully automated immunoassay for calcitonin. Clin Chem. 2017;63(9):1489–96. https://doi.org/10.1373/clinchem.2016.270009.CrossRefPubMed

12.

Vitale G, Ciccarelli A, Caraglia M, Galderisi M, Rossi R, Del Prete S, et al. Of two provocative tests for calcitonin in medullary thyroid carcinoma: omeprazole vs. pentagastrin. Clin Chem. 2002;48(9):1505–10.PubMed

13.

Erdoğan MF, Güllü S, Başkal N, Uysal AR, Kamel N, Erdoğan G. Omeprazole: calcitonin stimulation test for the diagnosis follow-up and family screening in medullary thyroid carcinoma. J Clin Endocrinol Metab. 1997;82(3):897–9. https://doi.org/10.1210/jcem.82.3.3797.CrossRefPubMed

14.

Kuroda K, Inhibitory AM. Effect of fumaric acid and dicarboxylic acids on gastric ulceration in rats. Arch Int Pharmacodyn Ther. 1977;226(2):324–30.PubMed

15.

Allelein S, Ehler M, Morneau C, Schwartz K, Goretzki PE, Seppel T, et al. Measurement of basal serum calcitonin for the diagnosis of medullary thyroid cancer. Horm Metab Res 2018;50(1):23–28.

Title: Editorial
Neuroendocrine neoplasms
Authors: Christian A. Koch
Stephan Petersenn
Publication date: 01-12-2017
Publisher: Springer US
Published in: Reviews in Endocrine and Metabolic Disorders / Issue 4/2017
Print ISSN: 1389-9155
Electronic ISSN: 1573-2606
DOI: https://doi.org/10.1007/s11154-018-9441-8

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2017

Echocardiography in functional midgut neuroendocrine tumors: When and how often

When should genetic testing be performed in patients with neuroendocrine tumours?

Hormone secreting gastro-entero-pancreatic neuroendocrine neoplasias (GEP-NEN): When to consider, how to diagnose?

Merkel cell carcinoma: Epidemiology, pathogenesis, diagnosis and therapy

Management of pulmonary neuroendocrine tumors

Chemotherapy in NETs: When and how

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage